Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 145 | 141 | 130 | 113 | 121 |
| Accounts receivable | 296 | 61 | 514 | 3,281 | -525 |
| Other Working Capital | 2,131 | -1,083 | 284 | 7,370 | 618 |
| Other Operating Activity | -4,294 | -1,069 | -5,188 | -11,599 | -3,675 |
| Operating Cash Flow | $-1,721 | $-1,949 | $-4,261 | $-836 | $-3,461 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -1,347 | -1,447 | -2,800 | -4,207 | -3,464 |
| Sale Of Investment | 1,756 | 86 | 1,450 | 5,451 | 0 |
| Investing Cash Flow | $408 | $-1,361 | $-1,350 | $1,244 | $-3,464 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 272 | 1,963 | 3,111 | 1,012 | -303 |
| Debt Repayment | -7 | -34 | -23 | -30 | -5 |
| Common Stock Issued | 0 | 0 | 0 | 1,485 | 7,045 |
| Other Financing Activity | -3 | -640 | 46 | 0 | 0 |
| Financing Cash Flow | $261 | $1,290 | $3,133 | $2,468 | $6,738 |
| Beginning Cash Position | 1,498 | 3,518 | 5,996 | 3,120 | 3,307 |
| End Cash Position | 446 | 1,498 | 3,518 | 5,996 | 3,120 |
| Net Cash Flow | $-1,052 | $-2,021 | $-2,478 | $2,876 | $-186 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,721 | -1,949 | -4,261 | -836 | -3,461 |
| Free Cash Flow | -1,721 | -1,949 | -4,261 | -836 | -3,461 |